Have a personal or library account? Click to login
Development of bioflavonoid containing chemotherapeutic delivery systems for UV-damaged skin and kangri cancer Cover

Development of bioflavonoid containing chemotherapeutic delivery systems for UV-damaged skin and kangri cancer

Forum of Clinical Oncology
Volume 12 (2021): Issue 3 (December 2021)
By: Harish Sharma,  Gyanesh Kumar Sahu and  Chanchal Deep Kaur  
Open Access
|Oct 2022

Authors

Harish Sharma

Shri Rawatpura Sarkar Institute of Pharmacy, Kumhari, India
Rungta Institute of Pharmaceutical Sciences, Kohka, Bhilai, India

Gyanesh Kumar Sahu

Rungta Institute of Pharmaceutical Sciences and Research, Bhilai, India
Rungta College of Pharmaceutical Sciences and Research, Bhilai, India

Chanchal Deep Kaur

drcdkresearch@gmail.com

Rungta College of Pharmaceutical Sciences and Research, Raipur, India
DOI: https://doi.org/10.2478/fco-2021-0012 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Journal RSS Feed
Language: English
Page range: 86 - 98
Submitted on: Nov 6, 2021
|
Accepted on: Jan 26, 2022
|
Published on: Oct 23, 2022
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
5-fluorouracil,
HET-CAM assay,
Kangri cancer,
microemulsion,
rutin,
stability
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology

© 2022 Harish Sharma, Gyanesh Kumar Sahu, Chanchal Deep Kaur, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 12 (2021): Issue 3 (December 2021)